← Leaderboards
Phillip A. Dennis
Clinical Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Sciences
Same institution · by research overlap
- Robert Yarchoan$0
- Andrew Blauvelt$331,401
- H Mitsuya$0
- Crystal L Mackall$137,564
- Carol Thiele-Galetto$0
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisMalignant Neoplasm Of LungClinical TrialsSeriesPathway InteractionsTumorMalignant NeoplasmsInhibitor/AntagonistDoseCancer CellPhosphotransferasesMolecularIn VivoNelfinavirDesignScreening ProcedureStressAutophagocytosisClinical ResearchHuman Frap1 ProteinChemotherapyPreclinical StudyCancer PatientPharmaceutical Preparations
Grant awards (32)
Signal Transduction Pathways that Promote Survival of Lung Cancer Cells$499,781
ZIA · FY2012 · CA · contact PI
Development of Akt Inhibitors$499,781
ZIA · FY2012 · CA · contact PI
Clinical Investigation of Signal Transduction Inhibitors$249,890
ZIA · FY2012 · CA · contact PI
Development of Akt Inhibitors$961,463
ZIA · FY2011 · CA · contact PI
Signal Transduction Pathways that Promote Survival of Lung Cancer Cells$961,463
ZIA · FY2011 · CA · contact PI
Clinical Investigation of Signal Transduction Inhibitors$480,732
ZIA · FY2011 · CA · contact PI
Development of Akt Inhibitors$1,169,414
ZIA · FY2010 · CA · contact PI
Signal Transduction Pathways that Promote Survival of Lung Cancer Cells$1,169,414
ZIA · FY2010 · CA · contact PI
Clinical Investigation of Signal Transduction Inhibitors$584,706
ZIA · FY2010 · CA · contact PI
Development of Akt Inhibitors$1,391,366
ZIA · FY2009 · CA · contact PI
Signal Transduction Pathways that Promote Survival of Lung Cancer Cells$1,391,366
ZIA · FY2009 · CA · contact PI
Clinical Investigation of Signal Transduction Inhibitors$695,684
ZIA · FY2009 · CA · contact PI
Development of Akt Inhibitors$775,221
Z01 · FY2008 · CA · contact PI
Signal Transduction Pathways that Promote Survival of Lung Cancer Cells$775,221
Z01 · FY2008 · CA · contact PI
Clinical Investigation of Signal Transduction Inhibitors$387,610
Z01 · FY2008 · CA · contact PI
Identification and regulation of signal transduction pathways that promote survi$2,338,621
Z01 · FY2007 · CA · contact PI
Development of Akt Inhibitors$2,338,621
Z01 · FY2007 · CA · contact PI
Clinical investigation of signal transduction inhibitors$1,224,349
Z01 · FY2007 · CA · contact PI
Clinical investigation of signal transduction inhibitors$0
Z01 · FY2006 · BC · contact PI
Development of Akt Inhibitors$0
Z01 · FY2006 · BC · contact PI
Identification and regulation of signal transduction pat$0
Z01 · FY2006 · SC · contact PI
Development of Akt Inhibitors$0
Z01 · FY2005 · BC
Identification and regulation of signal transduction pat$0
Z01 · FY2005 · SC
Development of Akt Inhibitors$0
Z01 · FY2004 · BC
Identification and regulation of signal transduction pat$0
Z01 · FY2003 · SC
Identification and regulation of signal transduction pat$0
Z01 · FY2002 · SC
Kinase activation and control of apoptosis in breast can$0
Z01 · FY2002 · SC
Development of Akt Inhibitors$0
Z01 · FY2002 · BC
Kinase activation and control of apoptosis in breast can$0
Z01 · FY2001 · SC
Signal Transduction Pathways--Lung Cancer Cell Survival$0
Z01 · FY2001 · SC
Kinase activation and control of apoptosis in breast cancer cells$0
Z01 · FY2000 · SC
Identification and regulation of signal transduction pathways that promote survi$0
Z01 · FY2000 · SC